Logo

Nanogen Subsidiary SynX Signs on Five European Distributors

Mar 08, 2005

NEW YORK, March 8 (GenomeWeb News) - Nanogen's subsidiary SynX has signed on five European distributors for its point-of-care diagnostics products, Nanogen said today.

 

The new distributors, which Nanogen did not name, expand SynX's coverage to 28 European countries. They will distribute and market SynX's point-of-care tests and research products for congestive heart failure and myocardial infarction.

 

SynX said its CHF diagnostic test is expected to lauch this year.

Breaking News
The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.